No results for ‘’
Ipca Laboratories Ltd
₹1636.30
(0.63%)
Wed, 27 May 2026, 05:43 pm
Ipca Laboratories Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 44.72 | 44.72 | 44.72 | 44.72 | 44.72 |
| FII | 10.63 | 10.63 | 10.42 | 10.67 | 10.76 |
| DII | 37.45 | 37.32 | 36.77 | 36.20 | 36.06 |
| Public | 7.20 | 7.33 | 8.08 | 8.40 | 8.46 |
| Government | 0 | 0 | 0 | 0 | 0 |
Ipca Laboratories Ltd Shareholding Pattern
The Ipca Laboratories Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Ipca Laboratories Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Ipca Laboratories Ltd (NSE: IPCALAB, BSE: 524494) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Ipca Laboratories Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Ipca Laboratories Ltd Shareholding Pattern (Latest)
The latest Ipca Laboratories Ltd shareholding for Mar 2026 is:
- Promoters: 44.72%
- FII: 10.63%
- DII: 37.45%
- Public: 7.20%
- Government: 0%
Promoter holding in Ipca Laboratories Ltd remains stable, reflecting consistent long-term commitment.
Ipca Laboratories Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Ipca Laboratories Ltd.
- Mar 2026: 44.72%
- Dec 2025: 44.72%
- Sept 2025: 44.72%
- Jun 2025: 44.72%
- Mar 2025: 44.72%
Promoter stake remains largely stable, showing consistent ownership structure.
Ipca Laboratories Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Ipca Laboratories Ltd.
- Mar 2026: 10.63%
- Dec 2025: 10.63%
- Sept 2025: 10.42%
- Jun 2025: 10.67%
- Mar 2025: 10.76%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Ipca Laboratories Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 37.45%
- Dec 2025: 37.32%
- Sept 2025: 36.77%
- Jun 2025: 36.20%
- Mar 2025: 36.06%
DII stake in Ipca Laboratories Ltd has increased over time, indicating growing domestic institutional confidence.
Ipca Laboratories Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 7.20%
- Dec 2025: 7.33%
- Sept 2025: 8.08%
- Jun 2025: 8.40%
- Mar 2025: 8.46%
Public holding remains stable with consistent retail participation.
Ipca Laboratories Ltd Government Holding
Government holding in Ipca Laboratories Ltd currently stands at 0%.
Ipca Laboratories Ltd operates without significant government ownership.
Ipca Laboratories Ltd Shareholding Analysis Summary
The Ipca Laboratories Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Ipca Laboratories Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Ipca Laboratories Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.